Administration of thiamazole for Graves’ disease might trigger the onset of type 1 diabetes

Documenti analoghi

• Bodyweight threshold for sudden onset of ketosis might exist in ketosis‐prone type 2 diabetes patients
  di: Satomura, Atsushi, et al.
  Pubblicazione: (2019)
• Clinical characterization of patients with primary aldosteronism plus subclinical Cushing’s syndrome
  di: Yasuda, Shigemitsu, et al.
  Pubblicazione: (2020)
• Weight control before and during pregnancy for patients with gestational diabetes mellitus
  di: Yasuda, Shigemitsu, et al.
  Pubblicazione: (2019)
• Simultaneous development of Graves’ disease and type 1 diabetes during anti‐programmed cell death‐1 therapy: A case report
  di: Kurihara, Susumu, et al.
  Pubblicazione: (2020)
• Intrinsic insulin secretion capacity might be preserved by discontinuing anti‐programmed cell death protein 1 antibody treatment in ‘anti‐programmed cell death protein 1 antibody‐induced’ fulminant type 1 diabetes
  di: Sakai, Gota, et al.
  Pubblicazione: (2018)